RxDoctor Payments Data

David Rustom, MD

Pain Medicine · Detroit, MINPI 1073877320

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,333 of the $6,404 with a category attached, or 83.3%. 14 manufacturers reported payments, led by Nalu Medical, Inc. at 30.6% of the total. Reporting peaked in 2024 at $2,161 and has fallen 55.3% since, to $967 in 2025.

$6,404in general payments, 2019–2025

Across 93 payments — averaging $68.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nalu Medical, Inc.$2K
  • Medtronic$1K
  • Nevro Corp.$528
  • Abbott$480
  • SPR Therapeutics, Inc$446
  • Vertos Medical, Inc.$435
  • plus $1K from 8 others
$12,561in research payments, 2019–2025

Across 1 payment — averaging $12,561 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • SPR Therapeutics, Inc$13K

What the payments were for

  • Consulting fees$4006%
  • Travel & lodging$67210%
  • Food & beverage$5,33383%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,404 in reported general payments places this provider in the 75th percentile of 139 pain medicine providers in Michigan.

See all pain medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$39,059
Medicare patients
105
Services billed
404

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen725$5,800
Diclofenac Sodium140$5,645
Lidocaine98$5,380
Gabapentin564$4,015
Pregabalin145$3,121
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl17$2,184
Celecoxib29$1,687
Tizanidine Hcl257$1,573
Acetaminophen-CodeineAcetaminophen With Codeine201$1,286
Naloxone Hcl14$1,193
Cyclobenzaprine Hcl156$1,000
Duloxetine Hcl78$899
Baclofen73$757
Amitriptyline Hcl94$548
Tramadol Hcl238$544

Paid to pharmacies, not to this prescriber.

Other pain medicine in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →